Arteris director sells 5,000 shares in plan trade

Arteris, Inc. director Chitkara Raman sold 5,000 shares of Common Stock in an open-market transaction.

Rhea-AI Filing Summary

Arteris, Inc. director Chitkara Raman sold 5,000 shares of Common Stock in an open-market transaction. The sale occurred on April 24, 2026 at a weighted average price of $25.0579 per share, with individual trades between $25.00 and $25.25.

The transaction was made under a pre-arranged Rule 10b5-1 trading plan adopted on March 7, 2025. Following this sale, Raman directly holds 147,867 shares of Arteris common stock.

Insider Trade Summary 10b5-1

Net Seller: 5,000 shares

Net Sell 1 txn

Insider Chitkara Raman

Role Director

Sold 5,000 shs ($125K)

Type	Security	Shares	Price	Value
Sale	Common Stock	5,000	$25.0579	$125K

Holdings After Transaction: Common Stock — 147,867 shares (Direct)

Footnotes (2)

1. F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 7, 2025.
2. F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.25 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 5,000 shares Weighted average sale price: $25.0579 per share Sale price range: $25.00 to $25.25 per share +2 more

5 metrics

Shares sold 5,000 shares Open-market sale on April 24, 2026

Weighted average sale price $25.0579 per share Common Stock sale on April 24, 2026

Sale price range $25.00 to $25.25 per share Multiple transactions included in reported sale

Shares owned after sale 147,867 shares Direct ownership following the reported transaction

10b5-1 plan adoption date March 7, 2025 Plan governing the April 24, 2026 sale

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, open-market sale, Common Stock

4 terms

Rule 10b5-1 trading plan financial

"Transaction made pursuant to a 10b5-1 trading plan that was adopted"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"The price reported in Column 4 is a weighted average sale price."

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

""security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Arteris (AIP) director Chitkara Raman report in this Form 4?

Director Chitkara Raman reported selling 5,000 shares of Arteris Common Stock. The sale was an open-market transaction executed on April 24, 2026, under a pre-arranged Rule 10b5-1 trading plan adopted in March 2025.

At what price did Chitkara Raman sell Arteris (AIP) shares?

The reported sale used a weighted average price of $25.0579 per share. According to the filing, individual trades occurred at prices ranging from $25.00 to $25.25 per share, all completed on April 24, 2026.

How many Arteris (AIP) shares does Chitkara Raman hold after this sale?

After selling 5,000 shares, Chitkara Raman directly holds 147,867 shares of Arteris Common Stock. This post-transaction ownership figure is disclosed in the Form 4 as the total shares beneficially owned following the reported sale.

Was the Arteris (AIP) insider sale made under a Rule 10b5-1 plan?

Yes. The filing states the transaction was made pursuant to a Rule 10b5-1 trading plan. That plan was adopted by the reporting person on March 7, 2025, indicating the sale was pre-arranged rather than a discretionary market-timed trade.

What type of transaction did Arteris (AIP) director Chitkara Raman execute?

The Form 4 describes the event as an open-market sale of Common Stock. It is classified with transaction code “S,” meaning a sale in the open market or a private transaction, reported as a non-derivative common stock transaction.

How many Arteris (AIP) shares did Chitkara Raman sell in total?

The insider sold a total of 5,000 shares of Arteris Common Stock. All of these shares are reported as part of a single non-derivative transaction dated April 24, 2026, with direct ownership status after the sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/28/2026 - 04:18 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chitkara Raman

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CALIFORNIA 95008

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/24/2026		S(1)		5,000	D	$25.0579(2)	147,867	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 7, 2025.

2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.25 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Paul Alpern, as Attorney-in-Fact for Chitkara Raman	04/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)